Latest RxSight Inc. (RXST) News on December 22, 2024
MT Newswires
2 days ago
Stifel Downgrades RxSight to Hold From Buy, Adjusts Price Target to $40 From $65
Simply Wall St.
2 days ago
Positive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past year
MT Newswires
11 days ago
Wells Fargo Downgrades RxSight to Equal Weight From Overweight, $56 Price Target
MT Newswires
a month ago
RxSight Insider Bought Shares Worth $1,014,570, According to a Recent SEC Filing
Simply Wall St.
a month ago
RxSight, Inc. (NASDAQ:RXST) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
GuruFocus.com
a month ago
RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ...
GlobeNewswire
2 months ago
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
MT Newswires
2 months ago
Rxsight Insider Sold Shares Worth $309,850, According to a Recent SEC Filing
MT Newswires
2 months ago
Rxsight Insider Sold Shares Worth $462,458, According to a Recent SEC Filing
Insider Monkey
2 months ago
RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now
MT Newswires
3 months ago
RxSight Insider Sold Shares Worth $328,164, According to a Recent SEC Filing
Simply Wall St.
3 months ago
Here's Why We're Not At All Concerned With RxSight's (NASDAQ:RXST) Cash Burn Situation
GlobeNewswire
4 months ago
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
MT Newswires
4 months ago
Needham Raises Price Target on RxSight to $66 From $54, Adds Stock to Conviction List, Keeps Buy Rating
Simply Wall St.
4 months ago
US$63.00: That's What Analysts Think RxSight, Inc. (NASDAQ:RXST) Is Worth After Its Latest Results
MT Newswires
5 months ago
Oppenheimer Adjusts RxSight Price Target to $65 From $72, Maintains Outperform Rating
MT Newswires
5 months ago
RxSight Reports Breakeven Q2 Adjusted Earnings as Revenue Increases; Raises 2024 Revenue Guidance
Simply Wall St.
5 months ago
Exploring Undervalued Small Caps With Insider Action In The United States July 2024
GlobeNewswire
5 months ago
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
Investor's Business Daily
5 months ago
Dow Jones Jumps 429 Points On Fed Chief's Comments; Gold Miners, Chips Rally (Live Coverage)
MT Newswires
5 months ago
Stifel Adjusts Price Target on RxSight to $70 From $75, Maintains Buy Rating
MT Newswires
6 months ago
RxSight Insider Sold Shares Worth $906,288, According to a Recent SEC Filing
GuruFocus.com
6 months ago
Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST)
Investor's Business Daily
6 months ago
Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock
Investor's Business Daily
6 months ago
These 5 Companies Lost Money. Here's Why They're Still On The IBD 50.
Investor's Business Daily
7 months ago
Why Top-Rated Medtech RxSight Has 20/20 Vision — And Is Seeing 55% Growth
MT Newswires
7 months ago
Rxsight Insider Bought Shares Worth $305,457, According to a Recent SEC Filing
Simply Wall St.
7 months ago
RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$72.75
MT Newswires
7 months ago
Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating
MT Newswires
8 months ago
Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating
MT Newswires
8 months ago
Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating
MT Newswires
8 months ago
BTIG Adjusts Price Target on RxSight to $72 From $61, Maintains Buy Rating
GuruFocus.com
8 months ago
RxSight Inc (RXST) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
MT Newswires
8 months ago
Rxsight Insider Sold Shares Worth $2,405,872, According to a Recent SEC Filing
MT Newswires
8 months ago
Rxsight Insider Sold Shares Worth $526,913, According to a Recent SEC Filing
GlobeNewswire
9 months ago
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Simply Wall St.
10 months ago
RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$57.75
GlobeNewswire
10 months ago
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
GuruFocus.com
10 months ago
RxSight Inc (RXST) Reports Significant Revenue Growth in Q4 and Full Year 2023
GlobeNewswire
10 months ago
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
10 months ago
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Business Wire
a year ago
RXO Announces Participation at Barclays 41st Annual Industrials Select Conference
Simply Wall St.
a year ago
With 64% institutional ownership, RxSight, Inc. (NASDAQ:RXST) is a favorite amongst the big guns
